OGT releases new application note detailing performance of two DNA labelling kits

Application note reveals superior performance of CytoSure Genomic DNA Labelling Kit

Oxford Gene Technology (OGT), The Molecular Genetics Company, has released a new application note detailing the technical evaluation of two DNA labelling kits, where OGT’s CytoSure Genomic DNA Labelling Kits were found to be quicker and more accurate than a leading alternative. Achieving efficient and uniform labelling of both test and reference DNA samples is critical for aCGH studies, enhancing data accuracy and interpretation. By ensuring greater accuracy, OGT’s kits vastly improve the identification of breakpoints and even the smallest aberrations, providing robust and invaluable insights into the underlying cause of genetic disorders.

During the evaluation, performance was judged on two key quality control metrics of the microarray: the derivative log ratio spread (DLRS), which calculates the probe-to-probe ‘noise’ and thereby indicates the uniformity and accuracy of labelling; and the signal-to-noise ratio, which indicates how accurately each ‘spot’ of signal can be detected. The application note details how, using commercially available DNA samples, CytoSure Genomic DNA Labelling Kits consistently generated both a lower DLRS (below 0.2) and higher signal-to-noise ratio (above 100), compared to the alternative supplier. OGT’s kits also undergo stringent quality control monitoring for every reagent batch to ensure reliable the delivery of such high quality results for every experiment.

CytoSure Genomic DNA Labelling Kits utilise heat rather than restriction enzymes to fragment the DNA samples, thereby streamlining the workflow and reducing loss off material. Removing the restriction digest stage saves approximately two hours, allowing the whole procedure to be easily completed in a single day.

These evidence-based findings from OGT highlight the superior performance of CytoSure Genomic DNA Labelling Kits, and this conclusion is also supported by extensive customer evaluations. The Cytogenetics Laboratory, Baylor College of Medicine, commented: “Our lab has tried a variety of different labelling methods and found OGT’s CytoSure Genomic DNA Labelling Kit to give consistently low DLRS values and excellent signal-to-noise ratios.”

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Oxford Gene Technology. (2019, June 20). OGT releases new application note detailing performance of two DNA labelling kits. News-Medical. Retrieved on November 22, 2024 from https://www.news-medical.net/news/20140423/OGT-releases-new-application-note-detailing-performance-of-two-DNA-labelling-kits.aspx.

  • MLA

    Oxford Gene Technology. "OGT releases new application note detailing performance of two DNA labelling kits". News-Medical. 22 November 2024. <https://www.news-medical.net/news/20140423/OGT-releases-new-application-note-detailing-performance-of-two-DNA-labelling-kits.aspx>.

  • Chicago

    Oxford Gene Technology. "OGT releases new application note detailing performance of two DNA labelling kits". News-Medical. https://www.news-medical.net/news/20140423/OGT-releases-new-application-note-detailing-performance-of-two-DNA-labelling-kits.aspx. (accessed November 22, 2024).

  • Harvard

    Oxford Gene Technology. 2019. OGT releases new application note detailing performance of two DNA labelling kits. News-Medical, viewed 22 November 2024, https://www.news-medical.net/news/20140423/OGT-releases-new-application-note-detailing-performance-of-two-DNA-labelling-kits.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
OGT announces launch of updated SureSeq Interpret NGS analysis software